HOME >> MEDICINE >> NEWS
Quality of treatment guidelines

Practising physicians are nowadays presented with official guidelines on the treatments they should give their patients. In an article published in PLoS Medicine, researchers have attempted to grade the quality of evidence used in drawing up the recommendations contained in guidelines for the treatment of patients with diabetes, high blood pressure and dyslipidemia (abnormal levels of fats in the blood).

Finlay McAlister and colleagues made use of the Canadian Hypertension Education Program (CHEP) grading scheme. They conclude that most recommendations are based on the results of well-conducted clinical trials. However, less than a third of the recommendations were found to be based on high-quality evidence applicable to the populations, treatments and outcomes specified in guideline recommendations. The researchers say that physicians should be aware that official guidelines are not necessarily based on high-quality evidence. They emphasize the need to make the evidence underlying guideline recommendations more transparent by using an extended grading system, like the CHEP scheme. If this were done, the researchers suggest, it would help clinicians to apply guideline recommendations appropriately to their individual patients.


'"/>

Contact: Andrew Hyde
ahyde@plos.org
44-122-346-3330
Public Library of Science
6-Aug-2007


Page: 1

Related medicine news :

1. Quality improvement effort pays off in diabetes care
2. Quality versus quantity -- transforming kidney transplant policy
3. Mayo Clinic ranked first in 2006 National Health Care Quality and Accountability
4. Quality care assessment examines surgical quality for colorectal cancer patients
5. ASCO and ESMO announce Consensus Statement on Quality Cancer Care
6. Quality of life can improve in old age, claim researchers
7. Quality of care in hospitals varies among regions and within individual hospitals
8. Quality measures need to be field-tested, researchers find
9. Quality of care not necessarily better in hospitals that participate in quality improvement program
10. Spot on treatment for acne
11. New treatment boosts muscle function in myasthenia gravis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Ron Norman, CEO of ... use the Law of Large Numbers in favor of senior, upper-level executive job candidates ... casinos, have long understood the Law of Large Numbers as a way of protecting ...
(Date:9/26/2017)... ... September 26, 2017 , ... CGL Electronic Security Inc., an ... its new umbrella, CGL Technologies, LLC. , The new CGL Technologies, LLC office is ... and Jon McCormack, both of whom have creative business development methods, who are responsive ...
(Date:9/26/2017)... Galloway, N.J. (PRWEB) , ... September 26, 2017 ... ... mocktail at the shore, the John R. Elliott HERO Campaign for Designated Drivers ... Hotel & Golf Club. , Thirty-one local bars and restaurants took on the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Founded as ... decades growing into an innovative leader in special education. In 2018, Glenholme will ... , Glenholme, formerly a world renowned horse farm for Hackney show ponies, was generously ...
(Date:9/26/2017)... ... September 26, 2017 , ... The 2017 American Academy of Cosmetic Surgery ... Fat,” revealed not only the latest about cosmetic procedures to remove and replace fat, ... cosmetic medicine. , “Fat really is magical, especially when it comes to the cosmetic ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a leading ... a vibrant charitable donation program -- "Color for ... congenital heart defect research by The Children,s Heart ... the general public are encouraged to download a ... the completed artwork to the gallery on the ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology:
Cached News: